- Home
- RNA vs RITM Comparison
RNA vs RITM Comparison
Compare RNA & RITM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNA
- RITM
- Stock Information
- Founded
- RNA 2012
- RITM 2011
- Country
- RNA United States
- RITM United States
- Employees
- RNA N/A
- RITM N/A
- Industry
- RNA Biotechnology: Pharmaceutical Preparations
- RITM Real Estate Investment Trusts
- Sector
- RNA Health Care
- RITM Real Estate
- Exchange
- RNA Nasdaq
- RITM Nasdaq
- Market Cap
- RNA 5.5B
- RITM 5.5B
- IPO Year
- RNA 2020
- RITM N/A
- Fundamental
- Price
- RNA $45.28
- RITM $10.76
- Analyst Decision
- RNA Strong Buy
- RITM Strong Buy
- Analyst Count
- RNA 9
- RITM 10
- Target Price
- RNA $63.22
- RITM $12.65
- AVG Volume (30 Days)
- RNA 1.0M
- RITM 4.3M
- Earning Date
- RNA 11-07-2024
- RITM 10-29-2024
- Dividend Yield
- RNA N/A
- RITM 9.28%
- EPS Growth
- RNA N/A
- RITM N/A
- EPS
- RNA N/A
- RITM 0.99
- Revenue
- RNA $10,117,000.00
- RITM $3,006,456,000.00
- Revenue This Year
- RNA $19.85
- RITM N/A
- Revenue Next Year
- RNA N/A
- RITM $4.33
- P/E Ratio
- RNA N/A
- RITM $10.92
- Revenue Growth
- RNA N/A
- RITM 1.78
- 52 Week Low
- RNA $5.68
- RITM $9.94
- 52 Week High
- RNA $56.00
- RITM $12.02
- Technical
- Relative Strength Index (RSI)
- RNA 48.69
- RITM 52.60
- Support Level
- RNA $45.65
- RITM $10.68
- Resistance Level
- RNA $56.00
- RITM $10.84
- Average True Range (ATR)
- RNA 3.07
- RITM 0.17
- MACD
- RNA 0.30
- RITM 0.05
- Stochastic Oscillator
- RNA 31.59
- RITM 83.00
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.
About RITM Rithm Capital Corp.
Rithm Capital Corp operates as a real estate investment trust that provides capital and services to the real estate and financial services industries. The company's mission is to generate attractive risk-adjusted returns in all interest-rate environments through a complementary portfolio of investments and operating businesses. Rithm Capital's investment portfolio is composed of mortgage servicing-related assets (full and excess MSRs and servicer advances), residential securities (and associated call rights) loans (including single-family rental), and consumer loans.